First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial

SM Lee; I Khan; S Upadhyay; C Lewanski; S Falk; G Skailes; E Marshall; PJ Woll; M Hatton; R Lal; R Jones; E Toy; D Chao; G Middleton; S Bulley; Y Ngai; R Rudd; A Hackshaw; C Boshoff

doi:10.1016/S1470-2045(12)70412-6

Back

First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial

Journal article

Peer reviewed

First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial

SM Lee, I Khan, S Upadhyay, C Lewanski, S Falk, G Skailes, E Marshall, PJ Woll, M Hatton, R Lal, …

LANCET ONCOLOGY, Vol.13(11), pp.1161-1170

01/11/2012

DOI: https://doi.org/10.1016/S1470-2045(12)70412-6

Abstract

Science & Technology

Life Sciences & Biomedicine

Oncology

ONCOLOGY

GROWTH-FACTOR RECEPTOR

METASTATIC COLORECTAL-CANCER

PERFORMANCE STATUS

STANDARD CHEMOTHERAPY

OPEN-LABEL

RASH

MULTICENTER

COMBINATION

GEFITINIB

CETUXIMAB

Files and links (1)

url

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310570900047&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View

Author

Metrics

28 Record Views

146 Times Cited - Web of Science

See more details

Details

Title: First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial
Creators: SM Lee
I Khan
S Upadhyay
C Lewanski
S Falk
G Skailes
E Marshall
PJ Woll
M Hatton
R Lal
R Jones
E Toy
D Chao
G Middleton
S Bulley
Y Ngai
R Rudd
A Hackshaw
C Boshoff
Publication Details: LANCET ONCOLOGY, Vol.13(11), pp.1161-1170
Publisher: ELSEVIER SCIENCE INC
Date published: 01/11/2012
Date submitted: 17/05/2017
Identifiers: 99511310902346
Academic Unit: University of Surrey
Language: English
Resource Type: Journal article

First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial

Abstract

Files and links (1)

Metrics

Details

Usage Policy